The use of efficacy animal models in breakpoint determination.
Aguilar
L
L
Medical Department, SmithKline Beecham Pharmaceuticals, Madrid, Spain.
Giménez
M J
MJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D006801:Humans
D000900:Anti-Bacterial Agents